The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research. His case fell far short.

Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...

The health secretary is one of the country's most prominent vaccine skeptics and has previously labeled the agency as a ...